Intel CEO announces boost to US manufacturing

By Nell Walker
Share
Intel CEO, Brian Krzanich, has revealed that the company will pour $7 billion into US manufacturing. On Wednesday, Krzanich stood alongside President D...

Intel CEO, Brian Krzanich, has revealed that the company will pour $7 billion into US manufacturing.

On Wednesday, Krzanich stood alongside President Donald Trump to make his announcement. He included an update on the company’s plant in Arizona, which has been under construction since 2011 and is set to be completed in three to four years.

The factory, named Fab 42, will apparently create 3,000 technical jobs and support 10,000 jobs within the local area in total.

Intel is one of many high-profile tech companies that, last weekend, signed an amicus brief which supports legal action against President Trump’s controversial travel ban, which could harm businesses such as theirs. However, another pledge of Trump’s – to lower corporate taxes – may benefit them. While Intel walks this tightrope alongside many others, it did not stop the company spending time with the President this week. Its $7 billion investment would already have occurred regardless of Trump’s administration, Intel Executive Vice President Stacy Smith told Financial Times.

Krzanich claimed last year not to endorse any specific candidate for the presidency, but that he himself was passionate about American manufacturing and prioritising US workers.

The majority of Intel’s manufacturing and R&D is undertaken in the States, while 80 percent of sales occur across the rest of the world, Krzanich told FT.

 

Follow @ManufacturingGL and @NellWalkerMG

 

 

Share

Featured Articles

Telix's bid to Expand Access to Cancer Radiopharmaceuticals

Rhine Pharma, spun off by Telix, aims to open production to improve worldwide access to radiopharmaceuticals for cancer imaging & treatment

UK Automotive Manufacturers Face Net Zero Challenge

A new BDO report shows how automotive suppliers are navigating the net zero transition, balancing immediate challenges with long-term sustainability goals

Samsung Biologics Secures US$1.24Bn Manufacturing Deal

Samsung Biologics signs contract with an Asia-based pharmaceutical company, to expand its global biomanufacturing capacity

How is ABB Revolutionising Automotive Sustainability?

Sustainability & ESG

Navigating Automotive Disruption: Eight Tips for Resilience

Production & Operations

BMW CEO: Industry not Ready for EU 2035 Petrol car ban

Sustainability & ESG